Inhibition of MSH release in frogs by direct application of L-proplyl-L-leucylglycinamide to the pituitary.
D000818:Animals; D001001:Anura; D001681:Biological Assay; D001769:Blood; D002449:Cell Aggregation / Q000187:drug effects; D004298:Dopamine / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D005998:Glycine / Q000494:pharmacology; D006493:Heparin / Q000494:pharmacology; D007031:Hypothalamus / Q000502:physiology; D007930:Leucine / Q000494:pharmacology; D008297:Male; D009074:Melanocyte-Stimulating Hormones / Q000037:antagonists & inhibitors*; D008544:Melanocytes / Q000187:drug effects*; D008550:Melatonin / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010455:Peptides / Q000494:pharmacology*; D010858:Pigmentation / Q000187:drug effects*; D010902:Pituitary Gland / Q000187:drug effects; D011392:Proline / Q000494:pharmacology; D011894:Rana pipiens
D010455:Peptides; D009074:Melanocyte-Stimulating Hormones; D006493:Heparin; D011392:Proline; D007930:Leucine; D008550:Melatonin; D005998:Glycine; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine